Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intersect ENT Inc (NASDAQ:XENT)

15.92
Delayed Data
As of Jul 27
 +0.22 / +1.40%
Today’s Change
11.88
Today|||52-Week Range
32.51
-29.24%
Year-to-Date

Today’s Trading

Previous close15.70
Today’s open15.68
Day’s range15.40 - 16.16
Volume260,295
Average volume (3 months)334,985
Market cap$444.7M
Dividend yield--
Data as of 3:59pm ET, 07/27/2016

Growth & Valuation

Earnings growth (last year)+36.65%
Earnings growth (this year)+1.09%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+59.67%
P/E ratioNM
Price/Sales9.73
Price/Book3.39

Competitors

 Today’s
change
Today’s
% change
MZORMazor Robotics Ltd0.000.00%
RMTIRockwell Medical Inc+0.14+1.76%
CYTXCytori Therapeutics ...+0.02+1.00%
ATRCAtriCure Inc-0.05-0.33%
Data as of 3:59pm ET, 07/27/2016

Financials

Next reporting dateAugust 31, 2016
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$60.5M
Annual profit (last year)-$26.6M
Net profit margin-44.03%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Lisa D. Earnhardt
COO, Senior VP-Research &
Development
Richard E. Kaufman
Corporate headquarters
Menlo Park, California

Forecasts

Partner Offers

Search for Jobs